retatrutide type 2 diabetes trial results 2024 Lilly's triple agonist achieves 16.8% weight loss in phase 3 retatrutide obesity phase 2 trial

Although this was an unselected sample of participants with respect to mental illness, nearly all participants had clinically significant depressive symptoms and anxiety

Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI

Lancet 368:16961705 Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, Porter L (2008) Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

We will look at the clinical trial currently underway, examine the 300% GLP-1 increase claim, and give you a clear framework for deciding whether resM belongs in your protocol or whether your money would be better spent elsewhere

I generally use a combination